CARLY KOELSCH: Open Payments
NPI 1982900098 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$84,102 in 215 payments from 17 companies in 2025. Trend: 2023 $33,913 · 2024 $99,135 · 2025 $84,102
Speaker / faculty: $65,400Travel & lodging: $14,716Food & beverage: $3,736Consulting: $250
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 92 | $48,939 |
| Lilly USA, LLC | 74 | $34,163 |
| Ardelyx, Inc. | 8 | $172 |
| GENZYME CORPORATION | 5 | $165 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $154 |
| Aimmune Therapeutics, Inc. | 5 | $98 |
| Janssen Biotech, Inc. | 3 | $81 |
| PFIZER INC. | 6 | $77 |
| Phathom Pharmaceuticals, Inc. | 4 | $57 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
Products named: OMVOH, SKYRIZI, RINVOQ, DUPIXENT, IBSRELA, ENTYVIO, VOWST, CREON.
Industry payments across FL — which companies pay providers there.
